Cargando…

Differential Effects of Ang-2/VEGF-A Inhibiting Antibodies in Combination with Radio- or Chemotherapy in Glioma

Antiangiogenic strategies have not shown striking antitumor activities in the majority of glioma patients so far. It is unclear which antiangiogenic combination regimen with standard therapy is most effective. Therefore, we compared anti-VEGF-A, anti-Ang2, and bispecific anti-Ang-2/VEGF-A antibody t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solecki, Gergely, Osswald, Matthias, Weber, Daniel, Glock, Malte, Ratliff, Miriam, Müller, Hans-Joachim, Krieter, Oliver, Kienast, Yvonne, Wick, Wolfgang, Winkler, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468722/ https://www.ncbi.nlm.nih.gov/pubmed/30845704 http://dx.doi.org/10.3390/cancers11030314

Ejemplares similares

Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells
por: Kovalchuk, Bogdana, et al.
Publicado: (2020)

Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
por: Jung, Erik, et al.
Publicado: (2021)

BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2
por: Wang, Fan, et al.
Publicado: (2021)

Progression Patterns in Non-Contrast-Enhancing Gliomas Support Brain Tumor Responsiveness to Surgical Lesions
por: Brenner, Steffen, et al.
Publicado: (2022)

Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions
por: Caporarello, Nunzia, et al.
Publicado: (2017)

Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
por: Foxton, Richard H, et al.
Publicado: (2019)

Treatment of glioblastoma in adults
por: Wick, Wolfgang, et al.
Publicado: (2018)

The impact of early RPE cell junction loss on VEGF, Ang-2, and TIMP secretion in vitro
por: Paterson, Chase, et al.
Publicado: (2023)

Brain Tumor Networks in Diffuse Glioma
por: Yang, Yvonne, et al.
Publicado: (2022)

Michel-Ange
por: Huyghe, René

Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
por: Wolf, Anne, et al.
Publicado: (2019)

Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
por: Andersen, Sigve, et al.
Publicado: (2011)

Granulocyte/Macrophage Colony-Stimulating Factor Influences Angiogenesis by Regulating the Coordinated Expression of VEGF and the Ang/Tie System
por: Zhao, Jingling, et al.
Publicado: (2014)

Anges et démons
por: Brown, Dan
Publicado: (2005)

Anges et démons
Publicado: (2009)

The History of Ang. Pect.
por: Bowcock, R. L.
Publicado: (1889)

Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response
por: Wang, Jin, et al.
Publicado: (2023)

l-Borneol Exerted the Neuroprotective Effect by Promoting Angiogenesis Coupled With Neurogenesis via Ang1-VEGF-BDNF Pathway
por: Ma, Rong, et al.
Publicado: (2021)

The Diagnostic Value of Serum Ang, VEGF, and CRP Combined with the Chinese Medicine Antitumor Formula in the Treatment of Advanced Renal Carcinoma
por: Dong, Nana, et al.
Publicado: (2021)

Engeletin protects against cerebral ischemia/reperfusion injury by modulating the VEGF/vasohibin and Ang-1/Tie-2 pathways
por: Liu, Hui, et al.
Publicado: (2021)

De Angelis : filosofía, mercado y postmodernidad /
por: Ripalda, José María
Publicado: (1996)

Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM)
por: Karimian-Jazi, Kianush, et al.
Publicado: (2020)

Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Aris Angelis (1954-2003)
Publicado: (2003)

Anges, Démons et Protons...
Publicado: (2009)

Pericytes Contribute to Dysfunction in a Human 3D Model of Placental Microvasculature through VEGF‐Ang‐Tie2 Signaling
por: Haase, Kristina, et al.
Publicado: (2019)

Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model
por: Mueller, Thomas, et al.
Publicado: (2019)

Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model
por: Hu, Alexander, et al.
Publicado: (2023)

Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis
por: Breckwoldt, Michael O, et al.
Publicado: (2016)

Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice
por: Schötterl, Sonja, et al.
Publicado: (2019)

Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling
por: Baker, Lauren CJ, et al.
Publicado: (2016)

Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment
por: Klaassen, Ingeborg, et al.
Publicado: (2022)

Les anges de l'univers /
por: Einar Már Gudmundsson
Publicado: (1998)

Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients
por: Robinson-Cohen, Cassianne, et al.
Publicado: (2016)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
por: Silva, Gabriela M., et al.
Publicado: (2020)

Le temps des anges ; Pile ou face /
por: Colomb, Catherine
Publicado: (1993)

Comparative evaluation of biased agonists Sarcosine(1), d‐Alanine (8) ‐Angiotensin (Ang) II (SD Ang II) and Sarcosine(1), Isoleucine (8) ‐Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT(1) receptors
por: Noto, Natalia M., et al.
Publicado: (2023)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1
por: Bertrand, Y, et al.
Publicado: (2011)

Massive perineal defect after radio‐chemotherapy
por: Zippi, Maddalena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ovfrkmofvb12tihjoo7hfc63o